Prophylactic Photodynamic Therapy to Organ Transplant Patients

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00365521

Enrollment

Registered

2006-08-17

Start date

2009-04-30

Completion date

Unknown

Last updated

2008-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Organ Transplants

Keywords

Organ transplant patients receiving immunosuppressive therapy

Brief summary

To evaluate a possible prophylactic efficacy of photodynamic therapy on the incidence of non-melanoma skin cancer, actinic keratoses, warts and keratoses in recently organ transplanted recipients.

Interventions

PROCEDUREPhotodynamic Therapy

Study design

Allocation

RANDOMIZED

Intervention model

SINGLE_GROUP

Masking

SINGLE

Eligibility

Sex/Gender

ALL

Age

40 Years to 70 Years

Healthy volunteers

Inclusion criteria

* Organ transplant recipients. * Age 40 years or older.

Exclusion criteria

* Patients younger than 40 years and older than 70 years. * Clinical signs of skin cancer, actinic keratoses or warts at the time of inclusion. * Previous photodynamic therapy to the skin areas investigated. * Pregnancy or breast feeding patients. * Patients with porphyria. * Patients with a tendency to produce hypertrophic scars or keloids. * Patients with known allergy to Metvix. * Patients who are not considered able to follow the treatment protocol (e.g. severely alcoholic patients, dementia patients, mentally ill patients etc.).

Countries

Denmark

Contacts

Primary ContactMerete Hædersdal, MD, PhD, DrMedSci

mhaedersdal@dadlnet.dk+45 35316002

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026